Lazard Capital Starts Aratana Therapeutics (PETX) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/14/2026
Go back to Lazard Capital Starts Aratana Therapeutics (PETX) at Buy
July 23, 2013 7:27 AM EDT
William Blair initiates coverage on Aratana Therapeutics (NASDAQ: PETX) with an Outperform.
For an analyst ratings summary and ratings history on Aratana Therapeutics click here. For more ratings news on Aratana Therapeutics click here.
Shares of Aratana Therapeutics closed at $10.12 yesterday, with a 52 week range of $6.56-$10.32.... More
July 22, 2013 9:01 AM EDT
JMP Securities initiates coverage on Aratana Therapeutics (NASDAQ: PETX) with a Market Outperform. PT $16.00.
For an analyst ratings summary and ratings history on Aratana Therapeutics click here. For more ratings news on Aratana Therapeutics click here.
Shares of Aratana Therapeutics closed at $9.57 yesterday, with a 52 week range of $6.56-$10.32.... More
July 22, 2013 9:00 AM EDT
Craig-Hallum initiates coverage on Aratana Therapeutics (NASDAQ: PETX) with a Buy. PT $15.00.
For an analyst ratings summary and ratings history on Aratana Therapeutics click here. For more ratings news on Aratana Therapeutics click here.
Shares of Aratana Therapeutics closed at $9.57 yesterday, with a 52 week range of $6.56-$10.32.... More
July 22, 2013 8:33 AM EDT
Stifel Nicolaus initiates coverage on Aratana Therapeutics (NASDAQ: PETX) with a Buy. PT $13.00.
For an analyst ratings summary and ratings history on Aratana Therapeutics click here. For more ratings news on Aratana Therapeutics click here.
Shares of Aratana Therapeutics closed at $9.57 yesterday, with a 52 week range of $6.56-$10.32.... More
